(Q45249147)
Statements
Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection (English)
hepatitis C virus
1 reference
Marshall J Glesby
Roland Bassett
Beverly Alston-Smith
Elizabeth L Jacobson
Clifford Brass
Susan Owens
Elizabeth M Race
Kenneth E Sherman
AIDS Clinical Trials Group A5088 Protocol Team